Elia Nathaniel, Quiñonez Marbella, Wu Fenfen, Mokhonova Ekaterina, DiFranco Marino, Spencer Melissa J, Cannon Stephen C
Department of Physiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.
Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1751.
Proc Natl Acad Sci U S A. 2025 Apr;122(13):e2418021122. doi: 10.1073/pnas.2418021122. Epub 2025 Mar 26.
Andersen-Tawil syndrome (ATS) is an ion channelopathy with variable penetrance for the triad of periodic paralysis, arrhythmia, and dysmorphia. Dominant-negative mutations of encoding the Kir2.1 potassium channel subunit are found in 60% of ATS families. As with most channelopathies, episodic attacks in ATS are frequently triggered by environmental stresses: exercise for periodic paralysis or stress with adrenergic stimulation for arrhythmia. Fluctuations in K, either low or high, are potent triggers for attacks of weakness in other variants of periodic paralysis (hypokalemic periodic paralysis or hyperkalemic periodic paralysis). For ATS, the [K] dependence is less clear; with reports describing weakness in high-K or low-K. Patient trials with controlled K challenges are not possible, due to arrhythmias. We have developed two mouse models (genetic and pharmacologic) with reduced Kir currents, to address the question of K-sensitive loss of force. These animal models and computational simulations both show K-dependent weakness occurs only when Kir current is <30% of wildtype. As the Kir deficit becomes more severe, the phenotype shifts from high-K-induced weakness to a combination where either high-K or low-K triggers weakness. A K channel agonist, retigabine, protects muscle from K-sensitive weakness in our mouse models of the skeletal muscle involvement in ATS.
安德森-陶威尔综合征(ATS)是一种离子通道病,其周期性麻痹、心律失常和畸形三联征的外显率可变。在60%的ATS家族中发现了编码Kir2.1钾通道亚基的显性负性突变。与大多数通道病一样,ATS的发作性发作常由环境应激触发:周期性麻痹由运动触发,心律失常由应激和肾上腺素能刺激触发。钾的波动,无论是低还是高,都是周期性麻痹其他变体(低钾性周期性麻痹或高钾性周期性麻痹)中肌无力发作的有效触发因素。对于ATS,钾依赖性尚不清楚;有报告描述了高钾或低钾时的肌无力。由于心律失常,无法进行钾负荷控制的患者试验。我们开发了两种Kir电流降低的小鼠模型(基因模型和药物模型),以解决钾敏感性肌力丧失的问题。这些动物模型和计算模拟均显示,仅当Kir电流<野生型的30%时才会出现钾依赖性肌无力。随着Kir缺陷变得更加严重,表型从高钾诱导的肌无力转变为高钾或低钾均可触发肌无力的组合。在我们的ATS骨骼肌受累小鼠模型中,钾通道激动剂瑞替加滨可保护肌肉免受钾敏感性肌无力的影响。